Skip to content

Blog

We regularly publish articles about both our own and external research, drug policy and education. This includes peer-reviewed publications, DSPL journal announcements, research reports and editorials. We welcome contributions from academics, researchers and students, so get in touch if you wish to submit an article. All content is reviewed before publishing by a member of our Scientific Committee to ensure it meets our quality standards.

Sophie Gorman – Medical Cannabis Patient Story

The UK Patient Conference is being held in central London and online, Friday 3 November 2023. It brings together patients, industry, healthcare professionals, charities and members of the public to discuss current issues in the medical cannabis space. Everyone is welcome. Buy a ticket from £5 In the lead up to…

From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia

Authors Octavian Dixon Ritchie, Cameron N Donley and Gabrielle Dixon Ritchie Published September 6, 2023 Background On February 3, 2023, the Therapeutic Goods Administration (TGA), Australian Government Department of Health and Aged Care, announced that on July 1, 2023, the psychedelics 3′4-methylenedioxymethamphetamine (MDMA) and psilocybin will be medically accessible and regulated…

Racial and religious motives for drug criminalization

Authors Petter Grahl Johnstad Published September 6, 2023 Abstract The world has a long-standing system of drug control intended to suppress the use of a range of psychoactive drugs on the basis that such use is very harmful both to the users themselves and to their social surroundings. This perception of…

MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians

Authors Anoek S Van Vugt, Josjan Zijlmans, Ramon Lindauer and Levi Van Dam Published September 1, 2023 Background PTSD in adolescence causes much suffering and has substantial health-care costs. Many patients with severe PTSD do not respond to psychotherapy or continue to have symptoms despite trauma-focused psychotherapies and psychopharmacological treatment. A…